Paying users zone. Data is covered by .

  • Get to Allergan PLC for $13.99, or

  • get to whole website for at least 3 months from $49.99.

$13.99

Statement of Financial Position, Liabilities and Stockholders' Equity Quarterly Data

Difficulty: Beginner

The statement of financial position provides creditors, investors, and analysts with information on company's resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company's assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Allergan PLC, Consolidated Statement of Financial Position, Liabilities and Stockholders' Equity (quarterly data)

USD $ in thousands

 
Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013
Accounts payable and accrued expenses
Income taxes payable
Current portion of long-term debt and capital leases
Deferred revenue
Current liabilities held for sale
Deferred tax liabilities
Current liabilities
Long-term debt and capital leases, excluding current portion
Other long-term liabilities
Long-term liabilities held for sale
Other taxes payable
Deferred tax liabilities
Non current liabilities
Total liabilities
Preferred shares, $0.0001 par value per share
Ordinary shares; $0.0001 par value per share
Treasury shares, at cost
Additional paid-in capital
Retained earnings (accumulated deficit)
Accumulated other comprehensive income (loss)
Shareholders' equity
Noncontrolling interest
Total equity
Total liabilities and equity
Source: Allergan PLC, Quarterly and Annual Reports
Item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Allergan PLC's current liabilities increased from Q3 2017 to Q4 2017 but then declined significantly from Q4 2017 to Q1 2018.
Non current liabilities Total obligations incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle. Allergan PLC's non current liabilities declined from Q3 2017 to Q4 2017 and from Q4 2017 to Q1 2018.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Allergan PLC's total liabilities declined from Q3 2017 to Q4 2017 and from Q4 2017 to Q1 2018.
Shareholders' equity Total of all Stockholders' Equity (deficit) items, net of receivables from officers, directors owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). Allergan PLC's shareholders' equity increased from Q3 2017 to Q4 2017 but then slightly declined from Q4 2017 to Q1 2018 not reaching Q3 2017 level.
Total equity Total of Stockholders' Equity (deficit) items, net of receivables from officers, directors owners, and affiliates of the entity including portions attributable to both the parent and noncontrolling interests (previously referred to as minority interest), if any. The entity including portions attributable to the parent and noncontrolling interests is sometimes referred to as the economic entity. Allergan PLC's total equity increased from Q3 2017 to Q4 2017 but then slightly declined from Q4 2017 to Q1 2018 not reaching Q3 2017 level.

Top